NOVARTIS AG-SPONSORED ADR
NVSNYSE🏆 #47 by market capEarnings Feb 2 · PostUS Equity
$156.08▼ $0.78 (−0.50%)
🌙 After hours$156.08▲ 0.00%Regular close · extended-hours price shownTrack NVS
Get earnings, price moves & breaking news on Telegram
24h▼ 0.5%
7d▼ 0.1%
14d▲ 3.8%
30d▲ 7.1%
ytd▲ 13.2%
1y▲ 28.2%
🏦Market Cap
$294.78B
Large Cap
📈Revenue Growth (YoY)
6.0%
Slowing
📊Gross Margin
74.3%
High
💵FCF Margin
27.9%
Strong
⚖️P/S Ratio
5.4x
Fair
Otter Score
80
Strong
NOVARTIS AG-SPONSORED ADR
NVSAnalyst Ratings
Price
$156.08
Total
25
Raised
8
Lowered
14
Avg PT
$149.50
H / L
$163 / $136
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HSBC | Upgraded | Reduce → Hold | 2026-09-10 | $136.00 | −12.90% |
Morgan Stanley | Reiterated | Overweight | 2026-03-26 | $163.00 | +4.40% |
Barclays | Upgraded | Underweight → Equal Weight | 2026-01-06 | — | — |
JP Morgan | Upgraded | Neutral → Overweight | 2025-12-08 | — | — |
Goldman Sachs | Downgraded | Neutral → Sell | 2025-09-12 | $121.00 | −22.50% |
UBS | Downgraded | Buy → Neutral | 2025-02-13 | — | — |
Erste Group | Downgraded | Buy → Hold | 2024-11-19 | — | — |
BMO Capital | Reiterated | Market Perform | 2024-10-30 | $120.00 | −23.10% |
B of A Securities | Downgraded | Buy → Neutral | 2024-09-11 | — | — |
Jefferies | Downgraded | Buy → Hold | 2024-09-03 | — | — |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2022-05-09 | — | — |
Exane BNP Paribas | Downgraded | Outperform → Neutral | 2021-12-06 | — | — |
Bryan Garnier | Downgraded | Buy → Neutral | 2021-12-03 | — | — |
Deutsche Bank | Downgraded | Hold → Sell | 2021-09-20 | — | — |
Argus Research | Downgraded | Buy → Hold | 2021-03-10 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2021-02-01 | — | — |
Guggenheim Securities | Downgraded | Buy → Neutral | 2020-02-25 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2020-02-25 | — | — |
Citigroup | Upgraded | Neutral → Buy | 2018-09-11 | — | — |
Bank of America | Upgraded | Underperform → Buy | 2018-09-10 | — | — |
Credit Suisse | Upgraded | Underperform → Neutral | 2018-05-25 | — | — |
Argus | Upgraded | Hold → Buy | 2018-05-05 | — | — |
Leerink Swann | Reiterated | Market Perform | 2018-01-25 | — | — |
Natixis | Upgraded | Neutral → Buy | 2015-03-04 | — | — |
Hamburger Sparkasse | Downgraded | Buy → Hold | 2013-01-16 | — | — |
Institution
HSBC
Upgraded · Reduce → Hold · 2026-09-10
$136.00
−12.90%
Morgan Stanley
Reiterated · Overweight · 2026-03-26
$163.00
+4.40%
Barclays
Upgraded · Underweight → Equal Weight · 2026-01-06
—
—
JP Morgan
Upgraded · Neutral → Overweight · 2025-12-08
—
—
Goldman Sachs
Downgraded · Neutral → Sell · 2025-09-12
$121.00
−22.50%
UBS
Downgraded · Buy → Neutral · 2025-02-13
—
—
Erste Group
Downgraded · Buy → Hold · 2024-11-19
—
—
BMO Capital
Reiterated · Market Perform · 2024-10-30
$120.00
−23.10%
B of A Securities
Downgraded · Buy → Neutral · 2024-09-11
—
—
Jefferies
Downgraded · Buy → Hold · 2024-09-03
—
—
Wolfe Research
Downgraded · Outperform → Peer Perform · 2022-05-09
—
—
Exane BNP Paribas
Downgraded · Outperform → Neutral · 2021-12-06
—
—
Bryan Garnier
Downgraded · Buy → Neutral · 2021-12-03
—
—
Deutsche Bank
Downgraded · Hold → Sell · 2021-09-20
—
—
Argus Research
Downgraded · Buy → Hold · 2021-03-10
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2021-02-01
—
—
Guggenheim Securities
Downgraded · Buy → Neutral · 2020-02-25
—
—
Guggenheim
Downgraded · Buy → Neutral · 2020-02-25
—
—
Citigroup
Upgraded · Neutral → Buy · 2018-09-11
—
—
Bank of America
Upgraded · Underperform → Buy · 2018-09-10
—
—
Credit Suisse
Upgraded · Underperform → Neutral · 2018-05-25
—
—
Argus
Upgraded · Hold → Buy · 2018-05-05
—
—
Leerink Swann
Reiterated · Market Perform · 2018-01-25
—
—
Natixis
Upgraded · Neutral → Buy · 2015-03-04
—
—
Hamburger Sparkasse
Downgraded · Buy → Hold · 2013-01-16
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space